DiCE Molecules designs and develops innovative therapies in immunology for patients with debilitating disease. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, they are developing oral alternatives to medicines currently limited to injectable forms. 

Biotechnology

DiCE Molecules

DiCE Molecules' headquarters in South San Francisco, CA, United States

J. Kevin Judice

Gary Brandt

Meina Tao Tang

Maureen Reilly

Nick Shah

Nico Ghilardi

Jeffrey Enejosa

Oliver Yasbek

Tania Santiago

The Clinical Operations and Management team at DiCE Molecules is responsible for the strategic planning, execution, and oversight of clinical trials. This team ensures that clinical studies adhere to regulatory standards and timelines, manages trial budgets, and coordinates cross-functional efforts to advance the development of innovative oral therapies. Key roles include overseeing clinical science, trial management, operations, statistical programming, and pharmacology to ensure robust and effective clinical development programs.

Clinical Operations and Management

The Leadership Team at DiCE Molecules is responsible for setting the strategic direction of the company and overseeing its operations to achieve innovative breakthroughs in immunology. Comprising the Founder & CEO, senior vice presidents, and vice presidents in key areas such as Drug Discovery and Medicinal Chemistry, the team collaborates to drive research, ensure financial sustainability, and foster partnerships that will lead to the development of effective oral therapies for patients with serious medical conditions. Their combined expertise guides the company's mission to transform treatment options and enhance patient care.

Leadership Team

The Development and Drug Discovery team at DiCE Molecules focuses on identifying and developing innovative oral therapies for immunological diseases. The team leverages cutting-edge pharmacological research, drug metabolism and pharmacokinetics (DMPK), and pharmaceutical development to create oral medications that are as effective as existing injectable biologics. This interdisciplinary team works together to turn scientific discoveries into viable treatment options for patients with serious medical conditions.

Development and Drug Discovery

The Chemistry Team at DiCE Molecules focuses on the design, development, and optimization of innovative small molecule therapies for immunological diseases. Comprised of experts in medicinal and analytical chemistry, the team collaborates to create efficacious oral medications as alternatives to injectable biologics, aiming to enhance patient convenience and treatment accessibility.

Chemistry Team

The Operations and IT Team at DiCE Molecules ensures seamless business operations and robust IT infrastructure, supporting the development of innovative immunology therapies. They manage technology implementation, vendor relations, operational efficiency, and strategic planning, enabling the company to focus on creating convenient oral alternatives to injectable medicines for patients with serious medical conditions.

DiCE Molecules

Org chart

Teams

Clinical Operations and Management

Leadership Team

Development and Drug Discovery

Chemistry Team

Operations and IT Team

Offices

DiCE Molecules

Org chart

Teams

Clinical Operations and Management

Leadership Team

Development and Drug Discovery

Chemistry Team

Operations and IT Team

Offices

Related companies